ABVC BioPharma, Inc. Increase (Decrease) in Accrued Liabilities
ABVC BioPharma, Inc. (ABVC) reported Increase (Decrease) in Accrued Liabilities of $65.03 thousand for the 9-month period ending 2017-06-30, per its 10-Q filed 2018-03-19.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccruedLiabilities · last filed 2018-03-19
- ABVC BioPharma, Inc. increase (decrease) in accrued liabilities for the quarter ending 2017-06-30 was $23.97K.
- ABVC BioPharma, Inc. increase (decrease) in accrued liabilities for the quarter ending 2015-12-31 was -$6.15K, a 697.09% decline year-over-year.
- ABVC BioPharma, Inc. increase (decrease) in accrued liabilities for the quarter ending 2014-12-31 was $1.03K.
- ABVC BioPharma, Inc. increase (decrease) in accrued liabilities for the quarter ending 2012-06-30 was $0.00.
- ABVC BioPharma, Inc. increase (decrease) in accrued liabilities for fiscal 2016 was $38.10K, a 644.14% increase from fiscal 2015.
- ABVC BioPharma, Inc. increase (decrease) in accrued liabilities for fiscal 2015 was $5.12K.
- ABVC BioPharma, Inc. increase (decrease) in accrued liabilities for fiscal 2014 was $0.00.
- ABVC BioPharma, Inc. increase (decrease) in accrued liabilities for fiscal 2011 was $146.45K.
| Period end | Increase (Decrease) in Accrued Liabilities 0 month | Increase (Decrease) in Accrued Liabilities 3 month | Increase (Decrease) in Accrued Liabilities 6 month | Increase (Decrease) in Accrued Liabilities 9 month | Increase (Decrease) in Accrued Liabilities 12 month |
|---|---|---|---|---|---|
| 2017-06-30 | $23.97K derived: 10-Q 9 month − 10-Q/A 6 month · filed 2018-03-19 | $65.03K 10-Q · filed 2018-03-19 | |||
| 2017-03-31 | $41.06K 10-Q/A · filed 2018-03-19 | ||||
| 2016-09-30 | $38.10K 10-K/A · filed 2017-09-22 | ||||
| 2015-12-31 | -$6.15K 10-Q · filed 2016-02-23 | ||||
| 2015-09-30 | $5.12K 10-K · filed 2015-11-27 | ||||
| 2014-12-31 | $1.03K 10-Q · filed 2016-02-23 | ||||
| 2014-09-30 | $17.23K 10-K · filed 2015-11-27 | ||||
| 2014-09-18 | $0.00 10-K · filed 2015-11-27 | ||||
| 2012-06-30 | $0.00 derived: 10-Q/A 9 month − 10-Q 6 month · filed 2012-08-20 | -$38.87K derived: sum of 2 quarters · filed 2012-08-20 | $5.83K 10-Q/A · filed 2012-08-20 | -$19.55K derived: sum of 4 quarters · filed 2012-08-20 | |
| 2012-03-31 | -$38.87K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-05-15 | $5.83K 10-Q · filed 2012-05-15 | -$19.55K derived: sum of 3 quarters · filed 2012-05-15 | -$22.67K derived: sum of 4 quarters · filed 2012-08-20 | |
| 2011-12-31 | $44.70K 10-Q · filed 2012-02-21 | $19.32K derived: sum of 2 quarters · filed 2012-02-21 | $16.20K derived: sum of 3 quarters · filed 2012-08-20 | $167.14K derived: sum of 4 quarters · filed 2012-08-20 | |
| 2011-09-30 | -$25.39K derived: 10-K/A 12 month − 10-Q/A 9 month · filed 2011-12-28 | -$28.50K derived: sum of 2 quarters · filed 2012-08-20 | $122.43K derived: sum of 3 quarters · filed 2012-08-20 | $146.45K 10-K/A · filed 2011-12-28 | |
| 2011-06-30 | -$3.12K derived: 10-Q/A 9 month − 10-Q 6 month · filed 2012-08-20 | $147.82K derived: sum of 2 quarters · filed 2012-08-20 | $171.84K 10-Q/A · filed 2012-08-20 | $176.41K derived: sum of 4 quarters · filed 2012-08-20 | |
| 2011-03-31 | $150.93K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-05-15 | $174.95K 10-Q · filed 2012-05-15 | $179.52K derived: sum of 3 quarters · filed 2012-05-15 | ||
| 2010-12-31 | $24.02K 10-Q · filed 2012-02-21 | $28.59K derived: sum of 2 quarters · filed 2012-02-21 | |||
| 2010-09-30 | $4.57K derived: 10-K/A 12 month − 10-Q/A 9 month · filed 2011-12-28 | -$4.58K 10-K/A · filed 2011-12-28 | |||
| 2010-06-30 | -$9.15K 10-Q/A · filed 2011-09-08 |